Dagmar Klotz

Papers

Total Citations

H-Index

About

Dagmar Klotz is a leading urologic oncologist whose research has fundamentally advanced the precision of prostate cancer surgery. Her work centers on the integration of advanced imaging, particularly multiparametric magnetic resonance imaging (MRI), into the surgical planning for radical prostatectomy. Klotz’s most impactful contribution is her landmark randomized clinical trial, which rigorously evaluated whether preoperative MRI could reduce the rate of positive surgical margins—a critical predictor of cancer recurrence. This study, cited 69 times, provided pivotal evidence that MRI-guided surgical planning can enhance the accuracy of tumor resection, directly improving oncologic outcomes. Beyond this trial, her research has shaped clinical guidelines on the use of imaging to tailor nerve-sparing techniques and optimize patient selection. With a career dedicated to bridging radiology and surgery, Klotz has been instrumental in demonstrating that personalized, image-driven approaches can minimize morbidity while maximizing cancer control. Her work continues to influence how surgeons visualize and excise prostate tumors, making her a key figure in the movement toward more precise, data-driven urologic oncology.